Publications by authors named "Fiona Collinson"

Claim this Profile
E
Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility study.
Leanne Shearsmith, Sarah Danson, Sarah Gelcich, Andrea Gibson, Kathryn Gordon, Fiona Collinson

Clin Trials· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.
Emma J West, Alain Sadoun, Kaidre Bendjama, Philippe Erbs, Cristina Smolenschi, Fiona J Collinson

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
Fiona Collinson, Kara-Louise Royle, Jayne Swain, Christy Ralph, Anthony Maraveyas

Health Technol Assess· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, Lisa Pickering, Tom Waddell, Fiona J Collinson

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial.
Divyalakshmi Bhaskaran, Joshua Savage, Amit Patel, Fiona Collinson, Rhys Mant

BMC Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
Mark A Hull, Pei Loo Ow, Sharon Ruddock, Tim Brend, Alexandra F Smith, Fiona Collinson

BMJ Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Janet E Brown, Kara-Louise Royle, Walter Gregory, Christy Ralph, Anthony Maraveyas, Fiona Collinson

Lancet Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Concurrent Chemoradiotherapy Add Meaningful Benefit in Addition to Induction Chemotherapy in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer?: A Systematic Review.
Animesh Saha, Jonathan Wadsley, Bhawna Sirohi, Rebecca Goody, Alan Anthony, Fiona Collinson

Pancreas· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.
Adel Samson, Emma J West, Jonathan Carmichael, Karen J Scott, Samantha Turnbull, Fiona Collinson

Cancer Immunol Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Konstantinos Kamposioras, George Papaxoinis, Mohamed Dawood, Jordan Appleyard, Fiona Collinson

Acta Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.
Emma J West, Karen J Scott, Emma Tidswell, Kaidre Bendjama, Nicolas Stojkowitz, Fiona J Collinson

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence of Low Anterior Resection Syndrome as Assessed in an International Randomized Controlled Trial (MRC/NIHR ROLARR).
William S Bolton, Stephen J Chapman, Neil Corrigan, Julie Croft, Fiona Collinson

Ann Surg· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.
Richard A Adams, David J Fisher, Janet Graham, Jenny F Seligmann, Matthew Seymour, Fiona Collinson

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of WEE1 Is Effective in - and -Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.
Jenny F Seligmann, David J Fisher, Louise C Brown, Richard A Adams, Janet Graham, Fiona Collinson

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer.
Jim Zhong, Ebrahim Palkhi, David L Buckley, Fiona J Collinson, Christy Ralph

Diagnostics (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group.
Janet E Brown, Catherine Handforth, Juliet E Compston, William Cross, Nigel Parr, Fiona J Collinson

J Bone Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.
Kevin N Franks, Lucy McParland, Joanne Webster, David R Baldwin, David Sebag-Montefiore, Fiona Collinson

Eur Respir J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Gerard M Walls, Jamie B Oughton, Anthony J Chalmers, Sarah Brown, Fiona Collinson

Clin Transl Radiat Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
Hannah L Buckley, Fiona J Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Adel Samson, Karen J Scott, David Taggart, Emma J West, Erica Wilson, Fiona J Collinson

Sci Transl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of establishing an academic early phase clinical trials unit.
Sarah R Brown, Debbie Sherratt, Gill Booth, Julia Brown, Fiona Collinson

Clin Trials· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.
Alison Young, Ernie Marshall, Monika Krzyzanowska, Bridget Robinson, Sean Brown, Fiona Collinson

Oncologist· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attaining surgical competency and its implications in surgical clinical trial design: a systematic review of the learning curve in laparoscopic and robot-assisted laparoscopic colorectal cancer surgery.
Jenifer Barrie, David G Jayne, Judy Wright, Carolyn J Czoski Murray, Fiona J Collinson

Ann Surg Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers and response to bevacizumab--response.
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, David A Cairns, Zougman Alexandre

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, David A Cairns, Alexandre Zougman

Clin Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis